{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:36:48Z","timestamp":1783528608054,"version":"3.55.0"},"reference-count":34,"publisher":"The Endocrine Society","issue":"4","funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000063","name":"NIH Office of Dietary Supplements","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000063","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Aims<\/jats:title>\n                    <jats:p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is linked to obesity, metabolic syndrome, and insulin resistance (IR). In IR associated with obesity or lipodystrophy (LD), caused by missing adipose tissue, hyperinsulinemia stimulates hepatic lipogenesis, causing steatotic liver disease (SLD). In contrast, insulin receptor pathogenic variants (INSR), despite hyperinsulinemia and IR, do not promote hepatic lipogenesis and steatosis. We aimed to understand SLD pathophysiology by comparing serum proteomic signatures of MASLD, LD, and INSR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Single-center study of fasting serum proteome using SomaScan assay in 30 LD, 29 INSR, and 16 people with MASLD. Key targets were assessed in the hepatic transcriptome of patients with MASLD (n = 19) and in HepG2 cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 6412 proteins, 567 differed between at least 2 groups. The proteome profiles clearly separated INSR from the other groups, whereas MASLD and LD displayed similarity, primarily in proteins involved in metabolism, liver injury, and fibrosis. Several proteins were uniquely elevated in INSR and LD compared to MASLD, particularly Factor IX and liver-expressed antimicrobial peptide 2. Serum levels of Factor IX and liver-expressed antimicrobial peptide 2 correlated with their hepatic expression, with in vitro expression unaffected by leptin, insulin, or glucose treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This first comparative proteomics study identified shared and unique pathways in IR disorders. MASLD and LD share features, suggesting similar drivers of liver disease progression. Key liver-derived proteins differ between MASLD, INSR, and LD because of unique disorder features. We demonstrate the utility of proteomics and rare disorder studies in interrogating pathogenesis of common disorders like MASLD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgaf516","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T11:37:56Z","timestamp":1759750676000},"page":"1057-1065","source":"Crossref","is-referenced-by-count":4,"title":["Serum Proteomics of Insulin Resistance Disorders Distinguish MASLD From Lipodystrophy and Insulin Receptor Defects"],"prefix":"10.1210","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9783-097X","authenticated-orcid":false,"given":"Maria","family":"Mironova","sequence":"first","affiliation":[{"name":"Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8993-199X","authenticated-orcid":false,"given":"Allison","family":"Wing","sequence":"additional","affiliation":[{"name":"Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent S","family":"Abel","sequence":"additional","affiliation":[{"name":"Diabetes Endocrinology and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health , Bethesda, MD 20892 ,","place":["USA"]},{"name":"Division of HIV, Infectious Diseases & Global Medicine, University of California San Francisco , San Francisco, CA 94143 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8222-6131","authenticated-orcid":false,"given":"Maren C","family":"Podszun","sequence":"additional","affiliation":[{"name":"Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health , Bethesda, MD 20892 ,","place":["USA"]},{"name":"Institute of Nutritional Sciences, University of Hohenheim , 70593 Stuttgart ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2589-7382","authenticated-orcid":false,"given":"Rebecca J","family":"Brown","sequence":"additional","affiliation":[{"name":"Diabetes Endocrinology and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7549-8216","authenticated-orcid":false,"given":"Yaron","family":"Rotman","sequence":"additional","affiliation":[{"name":"Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health , Bethesda, MD 20892 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2025,10,7]]},"reference":[{"issue":"4","key":"2026031619574873900_dgaf516-B1","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"issue":"10","key":"2026031619574873900_dgaf516-B2","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1172\/JCI129187","article-title":"Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome","volume":"129","author":"Kahn","year":"2019","journal-title":"J Clin Invest"},{"issue":"4","key":"2026031619574873900_dgaf516-B3","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1053\/j.gastro.2015.12.037","article-title":"Lipid-induced signaling causes release of inflammatory extracellular vesicles from hepatocytes","volume":"150","author":"Hirsova","year":"2016","journal-title":"Gastroenterology"},{"key":"2026031619574873900_dgaf516-B4","doi-asserted-by":"crossref","first-page":"1250203","DOI":"10.3389\/fendo.2023.1250203","article-title":"Natural history and comorbidities of generalised and partial lipodystrophy syndromes in Spain","volume":"14","author":"Fern\u00e1ndez-Pombo","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"2026031619574873900_dgaf516-B5","first-page":"315","article-title":"Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis","volume":"119","author":"Semple","year":"2009","journal-title":"J Clin Invest"},{"issue":"7","key":"2026031619574873900_dgaf516-B6","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1172\/JCI135431","article-title":"Free fatty acid processing diverges in human pathologic insulin resistance conditions","volume":"130","author":"Sekizkardes","year":"2020","journal-title":"J Clin Invest"},{"issue":"572","key":"2026031619574873900_dgaf516-B7","doi-asserted-by":"crossref","first-page":"eaba4448","DOI":"10.1126\/scitranslmed.aba4448","article-title":"Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis","volume":"12","author":"Govaere","year":"2020","journal-title":"Sci Transl Med"},{"issue":"8","key":"2026031619574873900_dgaf516-B8","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S2468-1253(23)00017-1","article-title":"Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study","volume":"8","author":"Vali","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5","key":"2026031619574873900_dgaf516-B9","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/hep4.1670","article-title":"SOMAscan proteomics identifies Serum biomarkers associated with liver fibrosis in patients with NASH","volume":"5","author":"Luo","year":"2021","journal-title":"Hepatol Commun"},{"issue":"7","key":"2026031619574873900_dgaf516-B10","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1053\/j.gastro.2022.03.004","article-title":"Postprandial plasma lipidomics reveal specific alteration of hepatic-derived diacylglycerols in nonalcoholic fatty liver disease","volume":"162","author":"Velenosi","year":"2022","journal-title":"Gastroenterology"},{"key":"2026031619574873900_dgaf516-B11","doi-asserted-by":"crossref","first-page":"101710","DOI":"10.1016\/j.redox.2020.101710","article-title":"Vitamin E treatment in NAFLD patients demonstrates that oxidative stress drives steatosis through upregulation of de-novo lipogenesis","volume":"37","author":"Podszun","year":"2020","journal-title":"Redox Biol"},{"key":"2026031619574873900_dgaf516-B12","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/978-1-4614-4118-2_20","article-title":"Highly multiplexed proteomic platform for biomarker discovery, diagnostics, and therapeutics","volume":"735","author":"Mehan","year":"2013","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"2026031619574873900_dgaf516-B13","doi-asserted-by":"crossref","first-page":"8382","DOI":"10.1038\/s41598-018-26640-w","article-title":"Stability and reproducibility of proteomic profiles measured with an aptamer-based platform","volume":"8","author":"Kim","year":"2018","journal-title":"Sci Rep"},{"key":"2026031619574873900_dgaf516-B14","doi-asserted-by":"publisher","author":"Mironova","year":"2025","DOI":"10.17632\/xwfwgngxvf.1"},{"issue":"9","key":"2026031619574873900_dgaf516-B15","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1016\/j.celrep.2019.07.091","article-title":"Molecular portraits of early rheumatoid arthritis identify clinical and treatment response phenotypes","volume":"28","author":"Lewis","year":"2019","journal-title":"Cell Rep"},{"issue":"2","key":"2026031619574873900_dgaf516-B16","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jhep.2018.04.018","article-title":"Liver\u2014master and servant of serum proteome","volume":"69","author":"Kuscuoglu","year":"2018","journal-title":"J Hepatol"},{"issue":"12","key":"2026031619574873900_dgaf516-B17","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1111\/liv.15707","article-title":"Divergent pathways of liver fat accumulation, oxidation, and secretion in lipodystrophy versus obesity-associated NAFLD","volume":"43","author":"Klein","year":"2023","journal-title":"Liver Int"},{"issue":"2","key":"2026031619574873900_dgaf516-B18","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1365-2796.2004.01426.x","article-title":"Adiponectin--journey from an adipocyte secretory protein to biomarker of the metabolic syndrome","volume":"257","author":"Trujillo","year":"2005","journal-title":"J Intern Med"},{"issue":"8","key":"2026031619574873900_dgaf516-B19","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1210\/jc.2006-0166","article-title":"Elevated plasma adiponectin in humans with genetically defective insulin receptors","volume":"91","author":"Semple","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026031619574873900_dgaf516-B20","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.tem.2015.01.002","article-title":"Adipocytokines and hepatic fibrosis","volume":"26","author":"Saxena","year":"2015","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"2026031619574873900_dgaf516-B21","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1210\/clinem\/dgad491","article-title":"Insulin signaling through the insulin receptor increases linear growth through effects on bone and the GH-IGF-1 axis","volume":"109","author":"Okawa","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026031619574873900_dgaf516-B22","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jhep.2022.11.029","article-title":"Defining the serum proteomic signature of hepatic steatosis, inflammation, ballooning and fibrosis in non-alcoholic fatty liver disease","volume":"78","author":"Sanyal","year":"2023","journal-title":"J Hepatol"},{"issue":"1","key":"2026031619574873900_dgaf516-B23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jhep.2021.09.026","article-title":"ADAMTSL2 protein and a soluble biomarker signature identify at-risk non-alcoholic steatohepatitis and fibrosis in adults with NAFLD","volume":"76","author":"Corey","year":"2022","journal-title":"J Hepatol"},{"issue":"4","key":"2026031619574873900_dgaf516-B24","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s42255-023-00775-1","article-title":"A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures","volume":"5","author":"Govaere","year":"2023","journal-title":"Nat Metab"},{"issue":"1","key":"2026031619574873900_dgaf516-B25","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/s41467-023-36858-6","article-title":"Tandem mass tag-based quantitative proteomic profiling identifies candidate serum biomarkers of drug-induced liver injury in humans","volume":"14","author":"Ravindra","year":"2023","journal-title":"Nat Commun"},{"issue":"2","key":"2026031619574873900_dgaf516-B26","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/hep.29802","article-title":"Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: an international collaborative effort","volume":"69","author":"Church","year":"2019","journal-title":"Hepatology"},{"issue":"2","key":"2026031619574873900_dgaf516-B27","doi-asserted-by":"crossref","first-page":"e520","DOI":"10.1210\/clinem\/dgaa792","article-title":"Relationship of IGF-1 and IGF-binding proteins to disease severity and glycemia in nonalcoholic fatty liver disease","volume":"106","author":"Stanley","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2026031619574873900_dgaf516-B28","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1111\/cts.13666","article-title":"Leukocyte cell-derived chemotaxin 2 correlates with pediatric non-alcoholic fatty liver disease","volume":"16","author":"Paine-Cabrera","year":"2023","journal-title":"Clin Transl Sci"},{"key":"2026031619574873900_dgaf516-B29","doi-asserted-by":"crossref","first-page":"104556","DOI":"10.1016\/j.jprot.2022.104556","article-title":"Serum proteome profiling reveals differentially expressed proteins between subjects with metabolically healthy obesity and nonalcoholic fatty liver disease","volume":"260","author":"Cheng","year":"2022","journal-title":"J Proteomics"},{"issue":"7","key":"2026031619574873900_dgaf516-B30","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1161\/CIRCRESAHA.123.322590","article-title":"Proteomic atlas of atherosclerosis: the contribution of proteoglycans to sex differences, plaque phenotypes, and outcomes","volume":"133","author":"Theofilatos","year":"2023","journal-title":"Circ Res"},{"issue":"8","key":"2026031619574873900_dgaf516-B31","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1055\/a-1210-2357","article-title":"Liver expressed antimicrobial peptide 2 is associated with steatosis in mice and humans","volume":"129","author":"Ma","year":"2021","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"9","key":"2026031619574873900_dgaf516-B32","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1172\/JCI125332","article-title":"LEAP2 changes with body mass and food intake in humans and mice","volume":"129","author":"Mani","year":"2019","journal-title":"J Clin Invest"},{"issue":"1","key":"2026031619574873900_dgaf516-B33","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/oby.2011.287","article-title":"Obesity-related derangements of coagulation and fibrinolysis: a study of obesity-discordant monozygotic twin pairs","volume":"20","author":"Kaye","year":"2012","journal-title":"Obesity (Silver Spring)"},{"issue":"2","key":"2026031619574873900_dgaf516-B34","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1478-3231.2010.02375.x","article-title":"Increased coagulation factor VIII, IX, XI and XII activities in non-alcoholic fatty liver disease","volume":"31","author":"Kotronen","year":"2011","journal-title":"Liver Int"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaf516\/64540812\/dgaf516.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/4\/1057\/64540812\/dgaf516.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/4\/1057\/64540812\/dgaf516.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T23:58:00Z","timestamp":1773705480000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/111\/4\/1057\/8277115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,7]]},"references-count":34,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,10,7]]},"published-print":{"date-parts":[[2026,3,17]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaf516","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2025,10,7]]}}}